Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,900
-80 (-0.67%)
Last updated: Jun 23, 2025

Whan In Pharm Revenue

Whan In Pharm had revenue of 60.20B KRW in the quarter ending March 31, 2025, a decrease of -2.29%. This brings the company's revenue in the last twelve months to 258.19B, up 9.19% year-over-year. In the year 2024, Whan In Pharm had annual revenue of 259.60B with 12.68% growth.

Revenue (ttm)
258.19B
Revenue Growth
+9.19%
P/S Ratio
0.70
Revenue / Employee
422.56M
Employees
611
Market Cap
180.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024259.60B29.20B12.68%
Dec 31, 2023230.39B31.46B15.81%
Dec 31, 2022198.93B21.16B11.90%
Dec 31, 2021177.78B6.07B3.54%
Dec 31, 2020171.71B12.53B7.87%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
Peptron 4.30B
Revenue Rankings